How are testosterone levels of patients with prostate cancer under treatment with Firmagon®
changing.
Former studies showed a quick fall of testosterone levels after start of therapy with
Firmagon® and a quick recovery when therapy is stopped. The investigators want to prove this
in a normal outpatient urologist setting. Furthermore data is collected to prove the
adherence to the German S3-Guideline for the treatment of prostate cancer.